Earningsreport

Q4/2023 12/31/2023 EPS -0.360 ZacksConsensus -0.380 ActVsEst 0.020 - Beat

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations